| Literature DB >> 31372555 |
Abstract
INTRODUCTION: Physical inactivity often accompanies chronic pathologies. This induces a sedentariness that favors complications and patient isolation. There is a growing scientific interest in the practice of art, for such activities leave the usual healthcare framework and include the World Health Organization (WHO)'s three dimensions of health. Dance is a universal activity that has been identified as healthy. This scoping review's aim is to study the benefits, modalities and risks of dance for persons with a chronic pathology.Entities:
Keywords: Cardiology; Chronic diseases; Dance; Evidence-based medicine; Health; Neurology; Oncology; Pathology; Pediatrics; Physical activity; Prevention; Rehabilitation
Year: 2019 PMID: 31372555 PMCID: PMC6657024 DOI: 10.1016/j.heliyon.2019.e02104
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Fig. 1Scoping review flow chart.
Geography, method and dance type information of included studies. The proportion is indicated by the percentage and the number of studies in brackets.
| Item | Caracteristics | Percentage |
|---|---|---|
| Localisation | Asia | 11.76% (6/51) |
| Europa | 29.41% (15/51) | |
| Africa | 1.97% (1/51) | |
| North America | 47.05% (24/51) | |
| South America | 7.84% (4/51) | |
| Australia-Oceania | 1,97% (1/51) | |
| Method | Case study | 27,46% (14/51) |
| Control study | 23.53% (12/51) | |
| Quasi-Randomized Controlled Trial | 1.97% (1/51) | |
| Randomized Controlled Trial | 47.05% (24/51) | |
| Dance type | Ballet danse | 5.88% (3/51) |
| Contemporary dance | 11.76% (6/51) | |
| Ballroom dance | 37.25% (19/51) | |
| Traditional dance | 15.69% (8/51) | |
| Fitness dance | 5.88% (3/51) | |
| Danse therapy | 17.66% (9/51) | |
| Various dance | 5.88% (3/51) |
Fig. 2Number of articles with keyword « dance » (in orange). In green, included studies by year of publication.
Fig. 3Main parameters assessed in the studies about dance and chronic diseases.
Fig. 4Distribution of articles about dance program and pathologies.
Synthesis of main effects studied and main results for neurological pathologies. The « N » corresponds to the number of studies. In the results part, the figure corresponds to the number of studies according with the beneficial effects or absence of effects.
| Pathologies | Parameters | Results (number of studies) | |
|---|---|---|---|
| Beneficial effect | No effect | ||
| Parkinson (N=16) | Adherence/satisfaction | 4 | 0 |
| Adverse effect | 0 | 1 | |
| Mental health (depression) | 4 | 0 | |
| Psycho-social aspects | 1 | 0 | |
| Cognition | 2 | 0 | |
| Quality of life | 2 | 1 | |
| Balance | 12 | 1 | |
| Gait and/or functional mobility | 8 | 2 | |
| Endurance | 1 | 0 | |
| Fatigue | 1 | 0 | |
| Spatio-temporal parameters of movement | 2 | 0 | |
| Symptoms | 5 | 2 | |
| Stroke (N=1) | Adherence/satisfaction | 1 | 0 |
| Balance | 1 | 0 | |
| Gait | 0 | 1 | |
| Multiple sclerosis (N=1) | Balance | 1 | 0 |
| Gait and/or functional mobility | 1 | 0 | |
| Fatigue | 1 | 0 | |
| Spinal cord (N=1) | Energetic demand | 1 | 0 |
| Cerebral palsy (N=5) | Adherence/satisfaction | 1 | 0 |
| Psycho-social aspects | 1 | 0 | |
| Cognition | 1 | 0 | |
| Balance | 3 | 0 | |
| Spatio-temporal parameters of movement | 2 | 0 | |
| Symptoms (mobility and function) | 2 | 1 | |
Synthesis of main effects studied and main results for other pathologies than neurological conditions. The « N » corresponds to the number of studies. In the results part, the figure corresponds to the number of studies according with the beneficial effects or absence of effects.
| Pathologies | Parameters | Results | |
|---|---|---|---|
| Beneficial effects | No effect | ||
| Fall (N = 2) | Balance | 1 | 0 |
| Gait | 1 | 0 | |
| Symptoms (fall risk) | 1 | 1 | |
| Schizophrenia (N = 2) | Quality of life | 1 | 0 |
| Balance | 1 | 0 | |
| Gait and/or functional mobility | 1 | 1 | |
| Muscular strenght | 1 | 0 | |
| Endurance | 0 | 1 | |
| Body mass index | 1 | 0 | |
| Mental retardation (N = 1) | Balance | 1 | 0 |
| Fibromyalgia (N = 2) | Adverse effect | 0 | 1 |
| Mental health | 2 | 0 | |
| Quality of life | 2 | 0 | |
| Gait | 1 | 1 | |
| Body mass index | 0 | 1 | |
| Symptoms (pain) | 2 | 0 | |
| Cancer (N = 7) | Adherence/satisfaction | 3 | 0 |
| Mental health (stress, anxiety, depression) | 3 | 1 | |
| Quality of life | 3 | 1 | |
| Gait and/or funtional mobility | 2 | 0 | |
| Fatigue | 1 | 0 | |
| Symptoms (pain, shoulder function) | 2 | 1 | |
| Rhumatoïd arthritis (N = 3) | Adherence/satisfaction | 1 | 0 |
| Adverse effect | 0 | 1 | |
| Mental health (depression) | 1 | 0 | |
| Gait and/or functional mobility | 1 | 0 | |
| Fatigue | 1 | 0 | |
| Symptoms (range of motion) | 1 | 1 | |
| Alzheimer (N = 1) | Balance | 1 | 0 |
| Gait and/or functional mobility | 1 | 0 | |
| Range of motion | 1 | 0 | |
| Low back pain (N = 1) | Work activities | 1 | 0 |
| Gait and/or functional mobility | 1 | 0 | |
| Symptoms (pain) | 1 | 0 | |
| Cardiac (N = 4) | Adherence/satisfaction | 1 | 0 |
| Adverse effect | 0 | 1 | |
| Mental health (motivation) | 1 | 0 | |
| Quality of life | 1 | 0 | |
| Balance | 1 | 0 | |
| Gait and/or functional mobility | 2 | 0 | |
| Muscular strenght | 1 | 0 | |
| Symptoms (CF, VO2, tension) | 2 | 1 | |
| Obesity (N = 2) | Adherence/satisfaction | 2 | 0 |
| Mental health (self esteem) | 1 | 0 | |
| Quality of life | 1 | 0 | |
| Gait and/or functional mobility | 0 | 1 | |
| Endurance/physical condition | 1 | 0 | |
| Symptoms (weight) | 2 | 0 | |
| Diabetes (N = 2) | Adherence/satisfaction | 1 | 0 |
| Endurance/physical condition | 1 | 0 | |